Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-1.04 %
$ 60.6 M
Market Cap
-167.0
P/E
ICCC - OPERATING INCOME
Operating Income ICCC - ImmuCell Corporation
-1.64 M
LAST VALUE
15.54%
2 YEAR CAGR
-11.44%
5 YEAR CAGR
-23.03%
10 YEAR CAGR